{
  "meta": {
    "timestamp": "2025-01-06T09:33:17.952567",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Chemed Corp",
      "symbol": "CHE",
      "analysis": {
        "historical": {
          "risk_score": 60,
          "key_risks": [
            "Regulatory and legal risks, including Medicare fraud allegations and dependence on government reimbursements",
            "Operational challenges such as labor shortages and economic sensitivity",
            "Financial and cost pressures from inflation and rising expenses"
          ],
          "controversies": [
            "$75 million settlement in 2017 for False Claims Act allegations related to Medicare fraud",
            "Ongoing regulatory scrutiny and compliance risks"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Labor shortages affecting service quality and operational efficiency",
            "Challenges in workforce management and retention"
          ],
          "governance_issues": [
            "Regulatory exposure and potential changes in Medicare reimbursement policies"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "$75M Medicare Whistleblower Settlement to be Paid by Chemed",
              "snippet": "The largest Medicare whistleblower settlement of $75 million will be paid by Chemed, a deal that was announced Monday, Oct. 30, 2017. Chemed did not admit liability, but its subsidiaries allegedly submitted false Medicare claims that gave rise to a government lawsuit and three whistleblower suits that were filed in the states of California, Illinois and Texas.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp Medicare fraud allegations",
              "retrieved_at": "2025-01-06T16:32:50.629501+00:00",
              "published_date": null,
              "source_hash": "d4a7b210e8579f1b3781d2ab71c7b217"
            },
            {
              "url": "",
              "title": "Office of Public Affairs | Chemed Corp. and Vitas Hospice Services ...",
              "snippet": "Chemed Corporation and various wholly-owned subsidiaries, including Vitas Hospice Services LLC and Vitas Healthcare Corporation, have agreed to pay $75 million to resolve a government lawsuit alleging that defendants violated the False Claims Act (FCA) by submitting false claims for hospice services to Medicare. Chemed, which is based in Cincinnati, Ohio, acquired Vitas in",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp Medicare fraud allegations",
              "retrieved_at": "2025-01-06T16:32:50.629600+00:00",
              "published_date": null,
              "source_hash": "0627ff4416d57c335b64c46d3ca094cb"
            },
            {
              "url": "",
              "title": "$75 Million Settlement reached to resolve False Claims Act Allegations ...",
              "snippet": "A settlement has been reached to resolve False Claims Act allegations against Chemed Corporation and Vitas Hospice Services. The allegations arose from a lawsuit that claimed Chemed Corporation and various wholly-owned subsidiaries, including Vitas Hospice Services LLC and Vitas Healthcare Corporation submitted false claims for hospice services to Medicare.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp Medicare fraud allegations",
              "retrieved_at": "2025-01-06T16:32:50.629614+00:00",
              "published_date": null,
              "source_hash": "308ea79224fddae14dc2cdeaaf19cfe5"
            },
            {
              "url": "",
              "title": "Chemed Corp. and Vitas Hospice Services Agree to Pay $75 Million to ...",
              "snippet": "Chemed Corporation and various wholly-owned subsidiaries, including Vitas Hospice Services LLC and Vitas Healthcare Corporation, have agreed to pay $75 million to resolve a government lawsuit alleging that defendants violated the False Claims Act (FCA) by submitting false claims for hospice services to Medicare. Chemed, which is based in ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp Medicare fraud allegations",
              "retrieved_at": "2025-01-06T16:32:50.629623+00:00",
              "published_date": null,
              "source_hash": "d7e1bf3ed1c68144e3dd2364d31800c3"
            },
            {
              "url": "",
              "title": "Chemed and Vitas Hospice Care Fraud Settlement Totals $75 Million",
              "snippet": "Cincinnati, Ohio - Oct. 30, 2017 - - Chemed Corporation and several subsidiaries, including Vitas Hospice Services LLC and Vitas Healthcare Corporation, will pay $75 million to resolve False Claims Act (FCA) allegations involving the submission of fraudulent claims to Medicare for hospice services. Vitas is the largest for-profit hospice chain in the United States.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp Medicare fraud allegations",
              "retrieved_at": "2025-01-06T16:32:50.629633+00:00",
              "published_date": null,
              "source_hash": "1c8e10cf73fb91f66d5a231e98b62e5d"
            },
            {
              "url": "",
              "title": "[Updated] $75 Million FCA Settlement is Largest-Ever for a Hospice",
              "snippet": "Continuous home care services can be provided under certain circumstances for hospice patients, and the care is the highest daily rate reimbursement that Medicare pays, according to the DOJ. Vitas and Chemed dispute the DOJ's allegations, and stated no admission or determination of wrongdoing in the settlement, Chemed stated in a press ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp Medicare fraud allegations",
              "retrieved_at": "2025-01-06T16:32:50.629641+00:00",
              "published_date": null,
              "source_hash": "cba3e7101090c84022759d463f818587"
            },
            {
              "url": "",
              "title": "United States Files False Claims Act Lawsuit - United States Department ...",
              "snippet": "The United States has filed suit against Chemed Corporation and various wholly owned hospice subsidiaries, including Vitas Hospice Services LLC and Vitas Healthcare Corporation, alleging false Medicare billings for hospice services, the Justice Department announced today. ... The claims asserted against Chemed and Vitas are allegations only ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp Medicare fraud allegations",
              "retrieved_at": "2025-01-06T16:32:50.629722+00:00",
              "published_date": null,
              "source_hash": "1c108334ba72c17adc003158e36ba5b8"
            },
            {
              "url": "",
              "title": "Largest-ever False Claims Act settlement with hospice provider",
              "snippet": "On October 30, 2017, the Department of Justice (DOJ) announced a $75 million settlement (the largest-ever settlement under the False Claims Act with a hospice provider) with Chemed Corporation, a Cincinnati-based operator of Vitas Hospice Services LLC and Vitas Healthcare Corp. (Vitas), to resolve allegations that between 2002 and 2013, Vitas submitted false claims to Medicare under the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp Medicare fraud allegations",
              "retrieved_at": "2025-01-06T16:32:50.629731+00:00",
              "published_date": null,
              "source_hash": "a37294dbdd6100e26a98a0cab8eb7c57"
            },
            {
              "url": "",
              "title": "Cases & Clients - Miner, Barnhill & Galland, P.C.",
              "snippet": "On October 30, 2017, the Department of Justice announced that Chemed Corporation and its wholly-owned subsidiaries Vitas Hospice Services LLC and Vitas Healthcare Corporation (\"Vitas\") agreed to pay $75 million to resolve allegations that they violated the False Claims Act (FCA) by submitting false claims for hospice services to Medicare ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp Medicare fraud allegations",
              "retrieved_at": "2025-01-06T16:32:50.629740+00:00",
              "published_date": null,
              "source_hash": "1f085840a8e24920086098da8ad6f93d"
            },
            {
              "url": "",
              "title": "Hospice provider to pay record-setting $75 million false claims ...",
              "snippet": "The federal suit, which was filed in 2013 and also named Vitas' parent company Chemed Corporation, additionally claims the provider submitted false Medicare claims for unnecessary home care ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp Medicare fraud allegations",
              "retrieved_at": "2025-01-06T16:32:50.629748+00:00",
              "published_date": null,
              "source_hash": "90ce7e044563a6bc6321d4e45f9f2760"
            },
            {
              "url": "",
              "title": "Chemed Reports Third-Quarter 2024 Results - Morningstar",
              "snippet": "Chemed Corporation ... 2023, the pretax and after-tax Retention Program expense was $23.7 million and $18.0 million, respectively. ... the current shortage of qualified nurses, other healthcare ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Chemed Corp Chemed Corp labor shortages and employee retention",
              "retrieved_at": "2025-01-06T16:32:54.791965+00:00",
              "published_date": null,
              "source_hash": "cd36eb815cc2d472b453626aac6b8ef8"
            },
            {
              "url": "",
              "title": "Chemed Reports Fourth-Quarter 2023 Results - Chemed Corporation",
              "snippet": "CINCINNATI--(BUSINESS WIRE)--Feb. 27, 2024-- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2023, versus ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Chemed Corp Chemed Corp labor shortages and employee retention",
              "retrieved_at": "2025-01-06T16:32:54.792077+00:00",
              "published_date": null,
              "source_hash": "9f25836d055f4f543681712a3dfa2230"
            },
            {
              "url": "",
              "title": "Chemed Reports Third-Quarter 2024 Results - Yahoo Finance",
              "snippet": "CINCINNATI, October 29, 2024--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Chemed Corp Chemed Corp labor shortages and employee retention",
              "retrieved_at": "2025-01-06T16:32:54.792101+00:00",
              "published_date": null,
              "source_hash": "f44f655c9f663502f5a1c787252bfe34"
            },
            {
              "url": "",
              "title": "Chemed Reports First-Quarter 2023 Results | Chemed Corporation",
              "snippet": "CINCINNATI--(BUSINESS WIRE)--Apr. 26, 2023-- Chemed Corporation (Chemed) ... This results in total licensed staff increasing by 475 professionals since the inception of the retention program on July 1, 2022. The increase of 200 professionals hired during the first quarter of 2023 is estimated to have negatively impacted margins in the quarter ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Chemed Corp Chemed Corp labor shortages and employee retention",
              "retrieved_at": "2025-01-06T16:32:54.792114+00:00",
              "published_date": null,
              "source_hash": "1a0b2cd284b85a543a76d175d0a6aa47"
            },
            {
              "url": "",
              "title": "Chemed Reports Third-Quarter 2023 Results Increases Full Year Guidance",
              "snippet": "CINCINNATI --(BUSINESS WIRE)--Oct. 25, 2023-- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation ... 12-month pandemic-related licensed healthcare professional retention bonus (Retention Program). Starting with the September 30, 2023 quarter, Chemed is no longer excluding the cost of the Retention Program when ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Chemed Corp Chemed Corp labor shortages and employee retention",
              "retrieved_at": "2025-01-06T16:32:54.792128+00:00",
              "published_date": null,
              "source_hash": "c188c6bd861d6baf1d7628ddce4b708f"
            },
            {
              "url": "",
              "title": "VITAS Deploys New Retention Program to Combat Labor Headwinds",
              "snippet": "VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHEM), recently launched a targeted hiring and retention wellness initiative designed to ease workforce strains and increase capacity for patient care, paving the way for sustainable long-term growth.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Chemed Corp Chemed Corp labor shortages and employee retention",
              "retrieved_at": "2025-01-06T16:32:54.792141+00:00",
              "published_date": null,
              "source_hash": "3b68e37a21c10dc796080e598fe0ea78"
            },
            {
              "url": "",
              "title": "Chemed (CHE) Faces Macroeconomic Woes, Tough Competition - Yahoo Finance",
              "snippet": "Chemed's CHE business suffers from headwinds like seasonality in business, competitive landscape and dependence on government mandates. The stock carries a Zacks Rank #4 (Sell). The stock ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Chemed Corp Chemed Corp labor shortages and employee retention",
              "retrieved_at": "2025-01-06T16:32:54.792155+00:00",
              "published_date": null,
              "source_hash": "f3cb33aa8e7bef0e6c5c738aac602246"
            },
            {
              "url": "",
              "title": "CHEMED CORP Management's Discussion and Analysis of Financial Condition ...",
              "snippet": "Based upon the above, full-year 2022 earnings per diluted share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation, retention program for licensed healthcare employees, and other discrete items, is estimated to be in the range of $19.60 to $19.70.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Chemed Corp Chemed Corp labor shortages and employee retention",
              "retrieved_at": "2025-01-06T16:32:54.792179+00:00",
              "published_date": null,
              "source_hash": "7ba74770dcd4537b7606d60685f0bbe0"
            },
            {
              "url": "",
              "title": "Chemed Reports Second-Quarter 2024 Results - Morningstar",
              "snippet": "Chemed Reports Second-Quarter 2024 Results. Chemed Corporation (Chemed) (NYSE: CHE),which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Chemed Corp Chemed Corp labor shortages and employee retention",
              "retrieved_at": "2025-01-06T16:32:54.792194+00:00",
              "published_date": null,
              "source_hash": "9ab0d5b81bb577b132de8e3541dd728c"
            },
            {
              "url": "",
              "title": "Staffing Pressures Top of Mind for VITAS Healthcare",
              "snippet": "COVID-19 headwinds continue to pose obstacles for hospice providers nationwide, including VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHEM). The company has recently seen drops in its patient census due to pandemic-related disruption, and maintaining staffing levels remains a top priority amid industry-wide shortages.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Chemed Corp Chemed Corp labor shortages and employee retention",
              "retrieved_at": "2025-01-06T16:32:54.792206+00:00",
              "published_date": null,
              "source_hash": "e4209845fe4e38f5e129978190dc8359"
            },
            {
              "url": "",
              "title": "Chemed Stock Hurt by Roto-Rooter Softness, Macro Issues Dent Growth",
              "snippet": "particularly in staffing and labor costs. In recent times, Chemed's performance has been affected by the inflationary trend, increased logistics costs, and higher employee-related expenses.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Chemed Corp Chemed Corp labor shortages and employee retention",
              "retrieved_at": "2025-01-06T16:32:58.132599+00:00",
              "published_date": "2024-11-22T20:23:00+00:00",
              "source_hash": "0d60e49998e2f08269f7451b2987cd66"
            },
            {
              "url": "",
              "title": "Chemed Corp - Internal Audit and Compliance - The Org",
              "snippet": "The Internal Audit and Compliance team at Chemed Corp is responsible for ensuring the integrity and accuracy of financial reporting, compliance with regulatory requirements, and the effectiveness of internal controls across the company's VITAS and Roto-Rooter segments. This includes conducting audits, identifying risks, implementing compliance ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp regulatory scrutiny and compliance audits",
              "retrieved_at": "2025-01-06T16:32:59.503647+00:00",
              "published_date": null,
              "source_hash": "c89b0d15a62255e8805ad5be68ad11b5"
            },
            {
              "url": "",
              "title": "Chemed Corp. 10-K - SEC.gov",
              "snippet": "Senior Subordinated Promissory Note dated as of October 11, 2002 by and among PCI Holding Corp. and Chemed Corporation. * 10.6 : Common Stock Purchase Warrant dated as of October 11, 2002 by and between PCI Holding Corp. and Chemed Corporation. * 10.7 : 1997 Stock Incentive Plan.*,** 10.8 : 1999 Stock Incentive Plan.*,** 10.9",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp regulatory scrutiny and compliance audits",
              "retrieved_at": "2025-01-06T16:32:59.503777+00:00",
              "published_date": null,
              "source_hash": "5166e5e4f1c5732d2b6ed3ac86de2dac"
            },
            {
              "url": "",
              "title": "Chemed Corporation | DEF 14A - SEC.gov",
              "snippet": "CHEMED CORPORATION AUDIT COMMITTEE CHARTER The Audit Committee is appointed by the Board to assist the Board in monitoring (1) the integrity of the financial statements of the Company, (2) the compliance by the Company with legal and regulatory requirements, and (3) the independence and performance of the Company's internal and external auditors.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp regulatory scrutiny and compliance audits",
              "retrieved_at": "2025-01-06T16:32:59.503800+00:00",
              "published_date": null,
              "source_hash": "41a7fb43879b2ccbf5e36dadd5895e95"
            },
            {
              "url": "",
              "title": "2022 ANNUAL REPORT - chemed.com",
              "snippet": "Chemed Corporation and Subsidiary Companies 3 Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. ... or that the degree of compliance with the policies or procedures may deteriorate. Critical Audit Matters The critical audit matter communicated below is a matter arising from ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp regulatory scrutiny and compliance audits",
              "retrieved_at": "2025-01-06T16:32:59.503816+00:00",
              "published_date": null,
              "source_hash": "a09d2fca6ff5e6449bfa9dd26729ee4f"
            },
            {
              "url": "",
              "title": "Documents & Charters - Chemed Corporation",
              "snippet": "Chemed intends to publish its comprehensive sustainability report, inclusive of SASB-aligned sustainability disclosures, no later than June 30, 2025.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp regulatory scrutiny and compliance audits",
              "retrieved_at": "2025-01-06T16:32:59.503829+00:00",
              "published_date": null,
              "source_hash": "67532e80240df7d18d41fffc728771b1"
            },
            {
              "url": "",
              "title": "Chemed Corporation Securities and Exchange Commission United States",
              "snippet": "The Annual Meeting of Stockholders of Chemed Corporation will be held at The Queen City Club, 331 East Fourth Street, Cincinnati, Ohio, on May 21, 2018, at 11:00 a.m. Eastern Time for the following purposes: (1)To elect directors; (2)To approve and adopt the Company's 2018 Stock Incentive Plan;",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp regulatory scrutiny and compliance audits",
              "retrieved_at": "2025-01-06T16:32:59.503841+00:00",
              "published_date": null,
              "source_hash": "99ea585c3201723e8d0de9068b371471"
            },
            {
              "url": "",
              "title": "Chemed Corp - Legal and Administrative Team - The Org",
              "snippet": "The Legal and Administrative Team at Chemed Corporation ensures the company's operations comply with all legal and regulatory requirements, manages corporate governance, and provides strategic planning and administrative support.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp regulatory scrutiny and compliance audits",
              "retrieved_at": "2025-01-06T16:32:59.503853+00:00",
              "published_date": null,
              "source_hash": "a65764f8386d5bef261138564722df4f"
            },
            {
              "url": "",
              "title": "Chemed Corp (CHE) 10-K Annual Report February 2021 - Last10K.com",
              "snippet": "Inside Chemed Corp's 10-K Annual Report: Financial - Expense Highlight. Environmental and safety compliance costs and liabilities could increase our expenses and adversely affect our financial condition. ... Federal and state legislative and regulatory initiatives could require VITAS to expend substantial sums on acquiring, implementing and ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp regulatory scrutiny and compliance audits",
              "retrieved_at": "2025-01-06T16:32:59.503864+00:00",
              "published_date": null,
              "source_hash": "91faf7d5494c3db9b34210750b04fd59"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "downloaded from Chemed's Web site at www.chemed.com. IndependentAccountants PricewaterhouseCoopers LLP Cincinnati, Ohio 45202 Annual Meeting The Annual Meeting of Shareholders of Chemed Corporation, will be held on Monday, May 21, 2018, at 11 a.m. in the Lower Level Conference Center ofThe Queen City Club, 331 East Fourth Street, Cincinnati ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp regulatory scrutiny and compliance audits",
              "retrieved_at": "2025-01-06T16:32:59.503876+00:00",
              "published_date": null,
              "source_hash": "f553debaae4bdb16823c34ac119dd14f"
            },
            {
              "url": "",
              "title": "Meet the Chemed Corporation Board of Directors - AdvisoryCloud",
              "snippet": "A: Chemed Corporation has faced lawsuits related to its billing practices and scrutiny from regulators over its compliance with healthcare regulations. To address these challenges, Chemed Corporation has implemented new policies and procedures, invested in training programs for its employees, and improved transparency and communication with ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Chemed Corp Chemed Corp regulatory scrutiny and compliance audits",
              "retrieved_at": "2025-01-06T16:32:59.503887+00:00",
              "published_date": null,
              "source_hash": "e90d4e831ef69ef38026cd9bb8f60a06"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Chemed Corp Medicare fraud allegations",
              "rationale": "Investigate past and ongoing legal issues related to Medicare billing practices at VITAS Healthcare",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "Chemed Corp labor shortages and employee retention",
              "rationale": "Explore challenges in recruiting and retaining skilled workers in both healthcare and trades sectors",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "Chemed Corp regulatory scrutiny and compliance audits",
              "rationale": "Assess the impact of increased regulatory oversight on VITAS Healthcare's operations and financial performance",
              "priority": 1
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T09:33:17.952592",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}